CHRISTINE HULBERT: Open Payments
NPI 1407921778 · CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,689 in 253 payments from 21 companies in 2025. Trend: 2023 $5,094 · 2024 $6,343 · 2025 $5,689
Food & beverage: $5,592Education: $97
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 38 | $1,166 |
| ABBVIE INC. | 56 | $1,112 |
| Janssen Biotech, Inc. | 23 | $604 |
| Lilly USA, LLC | 16 | $395 |
| Galderma Laboratories, L.P. | 23 | $321 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 10 | $285 |
| Amgen Inc. | 8 | $282 |
| Novartis Pharmaceuticals Corporation | 14 | $271 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $168 |
| Arcutis Biotherapeutics, Inc. | 14 | $163 |
Products named: Bimzelx, SKYRIZI, TREMFYA, TALTZ, DUPIXENT, RINVOQ, NEMLUVIO, OTEZLA.
Industry payments across MA — which companies pay providers there.
